Increased cell death also corresponds to decreased expression of genes that have been experimentally validated to support viability during Kras driven PanIN development and in PDA cells, such as Nupr1 and AGR2[35], [36], [37], [49]. The gene discussed is NUPR1; the disease is Patent ductus arteriosus.